Sector valuations Perspective Therapeutics, Inc.

Stocks

CATX

US46489V3024

Biotechnology & Medical Research

Market Closed - NYSE Other stock markets 01:30:00 29/07/2026 am IST			5-day change	1st Jan Change
2.870 ^USD	+1.77%		-3.69%	+4.36%

28/07	Perspective Therapeutics' Neuroendocrine Tumor Therapy Receives EU Orphan Drug Designation	MT
17/07	Perspective Therapeutics Data On 212Pb VMT-a-NET Accepted For Oral Presentation At ESMO Congress 2026	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	Price to Book (Y)	PEG (Y)	EV / Sales (Y)	EV / EBITDA (Y)	EV / EBIT (Y)	Dividend Yield (Y)	Capi.($)
PERSPECTIVE THERAPEUTICS, INC.	-2.6x	1.27x	0.12x	331.29x	-1.11x	-1.12x	-.--%	33Cr
LONZA GROUP AG	32.72x	4.38x	1.22x	5.89x	17.49x	24.51x	0.98%	4.79TCr
REVOLUTION MEDICINES, INC.	-22.95x	17.99x	-0.66x	343.53x	-20.98x	-20.91x	-.--%	3.91TCr
BEONE MEDICINES AG	49x	7.38x	0.29x	5.01x	32.38x	37.42x	-.--%	3.67TCr
IQVIA HOLDINGS INC.	31.16x	5.89x	-55.51x	3.12x	13.46x	20.4x	-.--%	4.05TCr
CELLTRION, INC.	27.11x	2.2x	0.57x	7.84x	19.63x	23.42x	0.43%	2.8TCr
MEDPACE HOLDINGS, INC.	32.47x	23.29x	2.15x	5.31x	24.11x	25.23x	-.--%	1.59TCr
EUROFINS SCIENTIFIC SE	22.79x	2.56x	0.65x	2x	8.65x	13.28x	1.16%	1.36TCr
ICON PUBLIC LIMITED COMPANY	25.48x	1.42x	0.18x	2.01x	12.17x	13.83x	-.--%	1.38TCr
BIO-TECHNE CORPORATION	61.86x	5.18x	0.4x	9.24x	26.24x	28.69x	0.44%	1.12TCr
ABIVAX	-30.68x	9.03x	1.15x	110.46x	-31.44x	-54.72x	-.--%	1.07TCr
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	39.22x	3.51x	-0.13x	3.48x	13.52x	16.51x	-.--%	1.16TCr
APOGEE THERAPEUTICS, INC.	-31.09x	8.99x	-13.65x	1000.32x	-26.52x	-25.98x	-.--%	1.01TCr
PHARMARON BEIJING CO., LTD.	35.15x	3.91x	2.47x	4.13x	17.39x	26.93x	0.64%	930.02Cr
IONIS PHARMACEUTICALS, INC.	-15.4x	240.77x	-0.3x	9.98x	-14.76x	-14.1x	-.--%	914.23Cr
KYMERA THERAPEUTICS, INC.	-30.24x	7.76x	6.24x	86.53x	-19.63x	-18.98x	-.--%	873.04Cr
PRAXIS PRECISION MEDICINES, INC.	-19.46x	7.36x	-1.52x	3321x	-16.32x	-15.9x	-.--%	824.68Cr
ALKERMES PLC	-102.03x	4.44x	0.76x	5.06x	25.14x	674.85x	-.--%	847.2Cr
PROTAGONIST THERAPEUTICS, INC.	32.21x	-	-0.1x	15.53x	28.78x	28.95x	-.--%	878.04Cr
Average	7.09x	19.85x	-2.93x	277.46x	5.69x	41.17x	0.19%	1.75TCr
Weighted average by Cap.	16.13x	14.23x	-6.63x	163.63x	9.05x	28.45x	0.26%